General Information of Drug Transporter (DT)
DT ID DTD0406 Transporter Info
Gene Name SLC56A4
Transporter Name Sideroflexin-4
Gene ID
119559
UniProt ID
Q6P4A7
Post-Translational Modification of This DT
Overview of SLC56A4 Modification Sites with Functional and Structural Information
Sequence
PTM type
X-Acetylation X-Oxidation X-Phosphorylation X-S-nitrosylation X-Ubiquitination X: Amino Acid

Acetylation

  Lysine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC56A4 [1]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

197

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC56A4 Lysine 197 has the potential to affect its expression or activity.

  Serine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC56A4 [2] , [3]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2

Experimental Method

Co-Immunoprecipitation

Detailed Description

Acetylation at SLC56A4 Serine 2 has the potential to affect its expression or activity.

Oxidation

  Cystine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SFXN4 [4]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

70

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SFXN4 Cystine 70 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SFXN4 [4]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

159

Experimental Method

Co-Immunoprecipitation

Detailed Description

Oxidation at SFXN4 Cystine 159 has the potential to affect its expression or activity.

Phosphorylation

  Serine

          3 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC56A4 [5] , [6]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

2

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC56A4 Serine 2 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC56A4 [7]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

101

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC56A4 Serine 101 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC56A4 [8]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

324

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC56A4 Serine 324 has the potential to affect its expression or activity.

  Threonine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC56A4 [9]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

9

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC56A4 Threonine 9 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC56A4 [8]

Role of PTM

Potential impacts

Modified Residue

Threonine

Modified Location

326

Experimental Method

Co-Immunoprecipitation

Detailed Description

Phosphorylation at SLC56A4 Threonine 326 has the potential to affect its expression or activity.

S-nitrosylation

  Cystine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SFXN4 [10]

Role of PTM

Potential impacts

Modified Residue

Cystine

Modified Location

159

Experimental Method

Co-Immunoprecipitation

Detailed Description

S-nitrosylation (-SNO) at SFXN4 Cystine 159 has the potential to affect its expression or activity.

Ubiquitination

  Alanine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC56A4 [11] , [12]

Role of PTM

Potential impacts

Modified Residue

Alanine

Modified Location

81

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC56A4 Alanine 81 has the potential to affect its expression or activity.

  Histidine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC56A4 [12]

Role of PTM

Potential impacts

Modified Residue

Histidine

Modified Location

97

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC56A4 Histidine 97 has the potential to affect its expression or activity.

  Leucine

          2 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC56A4 [12]

Role of PTM

Potential impacts

Modified Residue

Leucine

Modified Location

107

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC56A4 Leucine 107 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC56A4 [11] , [12]

Role of PTM

Potential impacts

Modified Residue

Leucine

Modified Location

114

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC56A4 Leucine 114 has the potential to affect its expression or activity.

  Lysine

          5 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC56A4 [11] , [13]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

106

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC56A4 Lysine 106 has the potential to affect its expression or activity.

  PTM Phenomenon 2

Have the potential to influence SLC56A4 [11] , [12]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

188

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC56A4 Lysine 188 has the potential to affect its expression or activity.

  PTM Phenomenon 3

Have the potential to influence SLC56A4 [11] , [13]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

197

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC56A4 Lysine 197 has the potential to affect its expression or activity.

  PTM Phenomenon 4

Have the potential to influence SLC56A4 [11] , [13]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

223

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC56A4 Lysine 223 has the potential to affect its expression or activity.

  PTM Phenomenon 5

Have the potential to influence SLC56A4 [11] , [13]

Role of PTM

Potential impacts

Modified Residue

Lysine

Modified Location

230

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC56A4 Lysine 230 has the potential to affect its expression or activity.

  Serine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC56A4 [11] , [12]

Role of PTM

Potential impacts

Modified Residue

Serine

Modified Location

221

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC56A4 Serine 221 has the potential to affect its expression or activity.

  Tyrosine

          1 PTM Phenomena Related to This Residue Click to Show/Hide the Full List

  PTM Phenomenon 1

Have the potential to influence SLC56A4 [12]

Role of PTM

Potential impacts

Modified Residue

Tyrosine

Modified Location

214

Experimental Method

Co-Immunoprecipitation

Detailed Description

Ubiquitination at SLC56A4 Tyrosine 214 has the potential to affect its expression or activity.
References
1 Lysine acetylation targets protein complexes and co-regulates major cellular functions. Science. 2009 Aug 14;325(5942):834-40.
2 Lys-N and trypsin cover complementary parts of the phosphoproteome in a refined SCX-based approach. Anal Chem. 2009 Jun 1;81(11):4493-501.
3 N-terminal acetylome analyses and functional insights of the N-terminal acetyltransferase NatB. Proc Natl Acad Sci U S A. 2012 Jul 31;109(31):12449-54.
4 Identifying Functional Cysteine Residues in the Mitochondria. ACS Chem Biol. 2017 Apr 21;12(4):947-957.
5 A Methodological Assessment and Characterization of Genetically-Driven Variation in Three Human Phosphoproteomes. Sci Rep. 2018 Aug 14;8(1):12106.
6 Phosphoproteome Integration Reveals Patient-Specific Networks in Prostate Cancer. Cell. 2016 Aug 11;166(4):1041-1054.
7 Global phosphoproteome analysis of human bone marrow reveals predictive phosphorylation markers for the treatment of acute myeloid leukemia with quizartinib. Leukemia. 2014 Mar;28(3):716-9.
8 Phosphoproteomic screening identifies Rab GTPases as novel downstream targets of PINK1. EMBO J. 2015 Nov 12;34(22):2840-61.
9 A fast sample processing strategy for large-scale profiling of human urine phosphoproteome by mass spectrometry. Talanta. 2018 Aug 1;185:166-173.
10 Dual Labeling Biotin Switch Assay to Reduce Bias Derived From Different Cysteine Subpopulations: A Method to Maximize S-Nitrosylation Detection. Circ Res. 2015 Oct 23;117(10):846-57.
11 A proteome-wide, quantitative survey of in vivo ubiquitylation sites reveals widespread regulatory roles. Mol Cell Proteomics. 2011 Oct;10(10):M111.013284.
12 Systematic functional prioritization of protein posttranslational modifications. Cell. 2012 Jul 20;150(2):413-25.
13 Systematic and quantitative assessment of the ubiquitin-modified proteome. Mol Cell. 2011 Oct 21;44(2):325-40.

If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.